Na, Deficit
normal value: 0 mEq
Estimates the risk of major cardiac complications after noncardiac surgery.
Indications for Use
Used to estimate perioperative MACE risk (high risk ≥1%) in adults undergoing elective, time‑sensitive, or urgent non‑cardiac surgery when clinical evaluation alone is insufficient (AHA/ACC 2024 1 [Level I evidence]). Clinical utility: quickly identifies low-risk patients (RCRI = 0) who need no further testing and patients with RCRI > 1 who warrant closer optimization or selective testing; performance is modest and less accurate in vascular surgery.
Insights & Cautions
Provides quick cardiac risk estimation but misses key outcomes: it underestimates risk in valvular disease and vascular surgery, and does not capture stroke, major bleeding, ICU need, or prolonged hospitalization 1 [Level I evidence]. Performance is only moderate (AUC ~0.75) and poorer in vascular surgery (AUC ~0.64) 2 [Level II evidence]. 2022–2024 guidelines do not endorse a single tool, so use it only as a rough estimate.